Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARTV Artiva Biotherapeutics, Inc.

未开盘 03-20 16:00:00 EDT

5.32

-0.20

-3.62%

盘后5.20

-0.12-2.26%

19:51 EDT

最高5.70	最低5.20	成交量8.94万
今开5.40	昨收5.52	日振幅9.06%
总市值1.31亿	流通市值2,863万	总股本2,472万
成交额47.93万	换手率1.66%	流通股本538.17万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":5.32,"timestamp":1774036800000,"preClose":5.52,"halted":0,"volume":89401,"hourTrading":{"tag":"盘后","latestPrice":5.2,"preClose":5.32,"latestTime":"19:51 EDT","volume":21346,"amount":113517.764,"timestamp":1774050688058,"change":-0.12,"changeRate":-0.022556,"amplitude":0.022556},"delay":0,"changeRate":-0.03623188405797089,"floatShares":5381708,"shares":24716672,"eps":-3.430895,"marketStatus":"未开盘","change":-0.2,"latestTime":"03-20 16:00:00 EDT","open":5.4,"high":5.7,"low":5.2,"amount":479322.925094,"amplitude":0.09058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.430895,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":0,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":5.52,"preHourTrading":{"tag":"盘前","latestPrice":5.69,"preClose":5.52,"latestTime":"08:00 EDT","volume":1,"amount":5.69,"timestamp":1774008004222,"change":0.17,"changeRate":0.030797,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.2,"preClose":5.32,"latestTime":"19:51 EDT","volume":21346,"amount":113517.764,"timestamp":1774050688058,"change":-0.12,"changeRate":-0.022556,"amplitude":0.022556},"volumeRatio":0.5758162825955059},"requestUrl":"/m/hq/s/ARTV","defaultTab":"news","newsList":[{"id":"2617544306","title":"Artiva Biotherapeutics, Inc.盘中异动 大幅上涨5.12%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617544306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617544306?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:50","pubTimestamp":1772639400,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时50分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速拉升5.12%。截至发稿，该股报5.75美元/股，成交量3.8538万股，换手率0.16%，振幅5.85%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Can Fite Biopharma Ltd、Moolec Science Sa C/Wts 30/01/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Can Fite Biopharma Ltd、Klotho Neurosciences, Inc.、Onconetix, Inc.较为活跃，换手率分别为2160.20%、59.34%、49.81%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Klotho Neurosciences, Inc.、Can Fite Biopharma Ltd，振幅分别为114.71%、51.24%、41.60%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603042350019543045e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603042350019543045e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2614735887","title":"Artiva Biotherapeutics, Inc.盘中异动 下午盘大幅拉升5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614735887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614735887?lang=zh_cn&edition=full","pubTime":"2026-02-27 03:50","pubTimestamp":1772135432,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日03时50分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速拉升5.47%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.91%。其相关个股中，Curanex Pharmaceuticals Inc、Klotho Neurosciences Inc C/Wts 21/06/2029 、Pmv Pharmaceuticals, Inc.涨幅较大，Curanex Pharmaceuticals Inc、Cardio Diagnostics Holdings Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为691.74%、146.98%、105.26%，振幅较大的相关个股有Curanex Pharmaceuticals Inc、Briacell Therapeutics Corp C/Wts 26/02/2026、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为68.49%、63.48%、55.17%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。该公司的管道项目包括artiva资助的试验和合作者资助的试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227035033a4cca08e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227035033a4cca08e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"1128732813","title":"Artiva Biotherapeutics任命Thad Huston为首席财务官并授予入职奖励股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1128732813","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128732813?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:08","pubTimestamp":1771938499,"startTime":"0","endTime":"0","summary":"2026年2月24日，临床阶段生物技术公司Artiva Biotherapeutics, Inc.宣布任命Thad Huston担任首席财务官。该公司致力于为严重自身免疫性疾病和癌症患者开发有效、安全且可及的细胞疗法。Huston先生在资本配置、运营执行和全球商业化方面拥有丰富经验，将助力Artiva推进AlloNK在自身免疫疾病领域的应用，并构建具备长期价值创造能力的组织体系。Huston持有宾夕法尼亚州立大学金融学士学位，并拥有注册管理会计师资质。作为入职激励，Artiva董事会批准向Huston先生授予22万份限制性股票单位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","ARTV","R","BK4139","BK4022"],"gpt_icon":0},{"id":"1137215798","title":"Artiva Biotherapeutics任命Thad Huston为首席财务官并授予入职奖励股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1137215798","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137215798?lang=zh_cn&edition=full","pubTime":"2026-02-24 21:05","pubTimestamp":1771938325,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics, Inc. (以下简称Artiva) 近日宣布，任命Thad Huston先生为公司首席财务官（CFO）。作为一项重要的高管入职激励措施，公司同时向Huston先生授予了相应的股权奖励。\nThad Huston在生物科技与制药行业拥有丰富的财务管理与资本运作经验，其加入将进一步加强Artiva在财务战略、资金管理及企业发展方面的领导力量。此次任命及股权授予符合公司吸引和保留顶尖人才的战略，旨在支持Artiva持续推进其细胞治疗产品管线的研发与商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2613485967","title":"Artiva Biotherapeutics, Inc.盘中异动 快速上涨6.20%报4.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613485967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613485967?lang=zh_cn&edition=full","pubTime":"2026-02-24 04:07","pubTimestamp":1771877243,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日04时07分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速上涨6.20%。截至发稿，该股报4.97美元/股，成交量8.8478万股，换手率0.36%，振幅10.03%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Arcellx, Inc.、Klotho Neurosciences, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Genprex, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为370.65%、237.08%、149.75%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Biovie Inc C/Wts 08/08/2030，振幅分别为70.43%、66.80%、49.38%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022404072497a6bd06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022404072497a6bd06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2611180995","title":"Artiva Biotherapeutics, Inc.盘中异动 大幅上涨6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611180995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611180995?lang=zh_cn&edition=full","pubTime":"2026-02-13 03:46","pubTimestamp":1770925603,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日03时46分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速上涨6.23%。截至发稿，该股报4.09美元/股，成交量11.0619万股，换手率0.45%，振幅7.92%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Galecto, Inc.、Karyopharm Therapeutics Inc.涨幅较大，Onconetix, Inc.、Quince Therapeutics, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为361.54%、229.50%、120.86%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Polaryx Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts ，振幅分别为62.50%、60.77%、44.39%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213034643a49d96f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213034643a49d96f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2610967056","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘快速跳水5.70%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610967056?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:52","pubTimestamp":1770648741,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时52分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速下跌5.70%。截至发稿，该股报3.80美元/股，成交量2.1443万股，换手率0.09%，振幅4.96%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Tuhura Biosciences, Inc.、Liminatus Pharma, Inc.、Lunai Bioworks Inc.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为75.37%、37.12%、21.29%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Genenta Science Spa、Ernexa Therapeutics Inc.，振幅分别为34.95%、28.39%、23.92%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602092252219540778d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602092252219540778d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2609913123","title":"Artiva Biotherapeutics, Inc.盘中异动 临近午盘急速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609913123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609913123?lang=zh_cn&edition=full","pubTime":"2026-02-05 00:44","pubTimestamp":1770223454,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日00时44分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下挫5.31%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Liminatus Pharma, Inc.、阿诺医药、Oncolytics Biotech Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Gri Bio, Inc.、Evogene Ltd.较为活跃，换手率分别为411.26%、207.41%、133.91%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Liminatus Pharma Inc C/Wts 30/04/2030 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为61.25%、35.12%、33.87%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。该公司的管道项目包括artiva资助的试验和合作者资助的试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205004415a47ca51a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205004415a47ca51a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"1158091432","title":"Artiva Biotherapeutics公布初步安全性和转化数据，支持使用Allonk®在自身免疫性疾病中实现深度B细胞耗竭","url":"https://stock-news.laohu8.com/highlight/detail?id=1158091432","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158091432?lang=zh_cn&edition=full","pubTime":"2025-11-12 20:21","pubTimestamp":1762950072,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics公布初步安全性和转化数据，支持使用Allonk®在自身免疫性疾病中实现深度B细胞耗竭","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2577550039","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577550039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577550039?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:52","pubTimestamp":1761227527,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时52分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速上涨5.58%。截至发稿，该股报4.73美元/股，成交量6.6268万股，换手率0.27%，振幅6.21%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Ventyx Biosciences, Inc.、Ibio, Inc.、Reviva Pharmaceuticals Holdings, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为150.77%、90.48%、75.22%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Tango Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为33.56%、31.18%、24.06%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023215207973eae12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023215207973eae12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2577899882","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌11.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577899882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577899882?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:32","pubTimestamp":1760967127,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时32分，Artiva Biotherapeutics, Inc.股票出现异动，股价大幅下挫11.31%。截至发稿，该股报5.33美元/股，成交量61.0355万股，换手率2.50%，振幅6.16%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Replimune Group, Inc.、Celcuity Inc.、Azitra Inc涨幅较大，Azitra Inc、Genprex, Inc.、Scisparc Ltd.较为活跃，换手率分别为1005.77%、284.77%、111.40%，振幅较大的相关个股有Ethzilla Corporation C/Wts 06/11/2025、Rapt Therapeutics, Inc.、Azitra Inc，振幅分别为17.30%、16.37%、10.76%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020213207a46a526d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020213207a46a526d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2576886096","title":"Os Therapies Incorporated盘中异动 快速下跌5.14%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576886096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576886096?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:13","pubTimestamp":1760710391,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时13分，Os Therapies Incorporated股票出现波动，股价急速下挫5.14%。截至发稿，该股报1.76美元/股，成交量33.3201万股，换手率0.99%，振幅6.91%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.05%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017221312a4654783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017221312a4654783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RANI","OS","ARTV","BK4539","OSTX","BK4007","BK4097","BK4139"],"gpt_icon":0},{"id":"2576101306","title":"Absci Corporation盘中异动 早盘大幅下跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576101306","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576101306?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:34","pubTimestamp":1760708046,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日21时34分，Absci Corporation股票出现异动，股价急速下挫5.85%。截至发稿，该股报4.59美元/股，成交量57.4068万股，换手率0.38%，振幅3.29%。Absci Corporation股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Xortx Therapeutics Inc.、Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.较为活跃，换手率分别为1021.57%、259.44%、129.63%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Adaptimmune Therapeutics Plc、冠科美博，振幅分别为33.98%、20.95%、18.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017213407a6bef5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017213407a6bef5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","RANI","BK4539","BK4007","BK4121","BK4139","ABSI"],"gpt_icon":0},{"id":"1127861636","title":"Artiva Biotherapeutics宣布抗药性类风湿关节炎为主要适应症及即将发布的数据和公司更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1127861636","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127861636?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:06","pubTimestamp":1760645170,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics宣布抗药性类风湿关节炎为主要适应症及即将发布的数据和公司更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2575794751","title":"Artiva Biotherapeutics, Inc.盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575794751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575794751?lang=zh_cn&edition=full","pubTime":"2025-10-16 03:47","pubTimestamp":1760557645,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日03时47分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速上涨5.05%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Genprex, Inc.、奥麦罗制药、Theriva Biologics, Inc.涨幅较大，Genprex, Inc.、Theriva Biologics, Inc.、奥麦罗制药较为活跃，换手率分别为2099.34%、1837.69%、178.52%，振幅较大的相关个股有Genprex, Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博，振幅分别为255.05%、156.54%、129.49%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。该公司的管道项目包括artiva资助的试验和合作者资助的试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510160347259730411a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510160347259730411a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2570839403","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570839403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570839403?lang=zh_cn&edition=full","pubTime":"2025-09-26 23:10","pubTimestamp":1758899412,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日23时10分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速下挫5.30%。截至发稿，该股报2.85美元/股，成交量12.5772万股，换手率0.51%，振幅3.99%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Curanex Pharmaceuticals Inc、Crinetics Pharmaceuticals, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Soligenix, Inc.、Plus Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为109.64%、79.94%、79.55%，振幅较大的相关个股有Curanex Pharmaceuticals Inc、Applied Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为55.96%、35.43%、29.81%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092623101297abcb72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092623101297abcb72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2568219423","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘大幅上涨6.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568219423","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568219423?lang=zh_cn&edition=full","pubTime":"2025-09-19 22:02","pubTimestamp":1758290559,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日22时02分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速上涨6.72%。截至发稿，该股报2.54美元/股，成交量3.1334万股，换手率0.13%，振幅4.62%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alx Oncology Holdings Inc.、Clearmind Medicine Inc.涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为581.41%、91.42%、78.84%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Alx Oncology Holdings Inc.，振幅分别为26.62%、24.93%、20.18%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919220239a72a7049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919220239a72a7049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2568467321","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨6.17%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568467321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568467321?lang=zh_cn&edition=full","pubTime":"2025-09-16 21:33","pubTimestamp":1758029586,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日21时33分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速拉升6.17%。截至发稿，该股报2.50美元/股，成交量978股，换手率0.00%，振幅0.00%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Aptevo Therapeutics Inc.、Surrozen Inc C/Wts 01/08/2031 、Adaptimmune Therapeutics Plc涨幅较大，Aptevo Therapeutics Inc.、Silo Pharma, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1435.91%、98.98%、71.44%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.、Relmada Therapeutics, Inc.，振幅分别为31.68%、29.86%、14.05%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509162133069531aca0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509162133069531aca0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2518273406","title":"Artiva Biotherapeutics, Inc.盘中异动 大幅下挫5.78%报5.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518273406?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:32","pubTimestamp":1741617139,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时32分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速下跌5.78%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3461.22%、735.14%、528.62%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.，振幅分别为41.36%、40.33%、40.24%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223219abf31348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223219abf31348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2517016480","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.12%报4.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517016480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517016480?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:24","pubTimestamp":1741274664,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时24分，Artiva Biotherapeutics, Inc.股票出现波动，股价快速拉升5.12%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.、Plus Therapeutics, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1547.16%、1402.06%、80.11%，振幅较大的相关个股有Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Moolec Science Sa C/Wts ，振幅分别为65.26%、44.64%、44.44%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232424a2629e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306232424a2629e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artivabio.com","stockEarnings":[{"period":"1week","weight":-0.1392},{"period":"1month","weight":0.2819},{"period":"3month","weight":0.1224},{"period":"6month","weight":0.8472},{"period":"1year","weight":0.3168},{"period":"ytd","weight":0.2401}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤（NK）细胞的疗法。","exchange":"NASDAQ","name":"Artiva Biotherapeutics, Inc.","nameEN":"Artiva Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artiva Biotherapeutics, Inc.(ARTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artiva Biotherapeutics, Inc.,ARTV,Artiva Biotherapeutics, Inc.股票,Artiva Biotherapeutics, Inc.股票老虎,Artiva Biotherapeutics, Inc.股票老虎国际,Artiva Biotherapeutics, Inc.行情,Artiva Biotherapeutics, Inc.股票行情,Artiva Biotherapeutics, Inc.股价,Artiva Biotherapeutics, Inc.股市,Artiva Biotherapeutics, Inc.股票价格,Artiva Biotherapeutics, Inc.股票交易,Artiva Biotherapeutics, Inc.股票购买,Artiva Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artiva Biotherapeutics, Inc.(ARTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}